| # | Drug | Count |
|---|---|---|
| 0 | ALBUTEROL SULFATE | 12 |
| 1 | FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE | 10 |
| 2 | CHOLESTYRAMINE | 9 |
| 3 | AMLODIPINE | 5 |
| 4 | ASPIRIN | 5 |
| 5 | FLUTICASONE PROPIONATE AND SALMETEROL | 4 |
| 6 | FUROSEMIDE | 4 |
| 7 | METHOTREXATE | 4 |
| 8 | METHOTREXATE SODIUM | 4 |
| 9 | POTASSIUM CHLORIDE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PANTHENOL | 1 | 0.0034 |
| 1 | CHOLESTYRAMINE | 9 | 0.0007 |
| 2 | LEVALBUTEROL TARTRATE | 2 | 0.0005 |
| 3 | MINOCYCLINE HYDROCHLORIDE | 2 | 0.0003 |
| 4 | FEXOFENADINE HCL | 1 | 0.0003 |
| 5 | CALCIPOTRIENE | 1 | 0.0003 |
| 6 | FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE | 10 | 0.0002 |
| 7 | PRAMIPEXOLE DIHYDROCHLORIDE | 1 | 0.0002 |
| 8 | TRANEXAMIC ACID | 1 | 0.0001 |
| 9 | TIZANIDINE HYDROCHLORIDE | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bile Acid Sequestrant [EPC] | 9 | 0.0007 |
| 1 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 2 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 3 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 4 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |
| 6 | Non-narcotic Antitussive [EPC] | 1 | 0.0001 |
| 7 | Vitamin D Analog [EPC] | 1 | 0.0001 |
| 8 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 9 | Progesterone [EPC] | 1 | 0.0000 |